Abstract

Inhibition of the Sialoglycan–Siglec Axis Promotes the Antitumor Activity of Chimeric Antigen Receptor-Engineered Macrophages

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call